
By PR Newswire | Article Rating: |
|
August 7, 2014 02:54 PM EDT | Reads: |
319 |

MIAMI, Aug. 7, 2014 /PRNewswire/ -- NextSource Biotechnology (NSB) is a leading specialty pharmaceutical manufacturer with a focus on identifying and developing the most viable pipeline of "matured" and "innovative drugs" in today's global healthcare market.
The product name change from Lomustine (CCNU) to GleostineTM represents the company's strategic initiative to re-launch and re-brand its product pipeline of matured and innovative drugs. The new GleostineTM product labeling will be visible in the healthcare market by the fourth quarter of 2014. Lomustine is currently available through all payer organizations nationwide – including both commercial and government providers of prescription drug coverage.
GleostineTM is a sole source FDA approved product, which is also accessible through NextSource CARES, NSB's patient assistance program. As a result of the company's extensive market access efforts, the continued use of unregulated compounded products or any other unapproved versions of GleostineTM, will continue to present an unnecessary risk to both healthcare providers and patients. NextSource Biotechnology is committed to providing the highest quality product with a consistent market supply.
"The re-branding of GleostineTM," said Robert DiCrisci, President, CEO of NextSource Biotechnology, "is the first of many product launches to come. As this initiative continues, we will expand our product line to ensure consistent availability to patients with critical medical need."
About NextSource Biotechnology: Established in 2010, NextSource Biotechnology is a leading specialty pharmaceutical manufacturer with a focus on identifying and developing the most viable pipeline of "Matured" and "Innovative drugs" in today's global healthcare market. NextSource partner, CordenPharma Latina is an expert contract manufacturer helping leading pharmaceutical and Biotechnology companies link their requirements for product success with their patients' healthier lives.
Logo - http://photos.prnewswire.com/prnh/20140124/FL52230LOGO
SOURCE NextSource Biotechnology
Published August 7, 2014 Reads 319
Copyright © 2014 SYS-CON Media, Inc. — All Rights Reserved.
Syndicated stories and blog feeds, all rights reserved by the author.
More Stories By PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
![]() Apr. 19, 2018 06:00 AM EDT Reads: 5,671 |
By Liz McMillan ![]() Apr. 19, 2018 06:00 AM EDT Reads: 1,951 |
By Pat Romanski Apr. 19, 2018 05:30 AM EDT Reads: 1,641 |
By Yeshim Deniz ![]() Apr. 19, 2018 05:15 AM EDT Reads: 1,782 |
By Pat Romanski ![]() Apr. 19, 2018 05:00 AM EDT Reads: 3,622 |
By Pat Romanski ![]() Apr. 19, 2018 04:30 AM EDT Reads: 5,030 |
By Elizabeth White ![]() Apr. 19, 2018 03:45 AM EDT Reads: 780 |
By SmartBear Blog ![]() Apr. 19, 2018 03:45 AM EDT Reads: 1,632 |
By Yeshim Deniz Apr. 19, 2018 03:45 AM EDT Reads: 780 |
By Elizabeth White Apr. 19, 2018 03:30 AM EDT Reads: 1,770 |
By Pat Romanski ![]() Apr. 19, 2018 03:15 AM EDT Reads: 7,052 |
By Yeshim Deniz Apr. 19, 2018 03:00 AM EDT Reads: 1,060 |
By Elizabeth White ![]() Apr. 19, 2018 02:45 AM EDT Reads: 4,665 |
By Pat Romanski Apr. 19, 2018 02:00 AM EDT Reads: 1,772 |
By Yeshim Deniz Apr. 19, 2018 01:45 AM EDT Reads: 4,611 |